Cardiol Therapeutics’ stock down 20% on Phase II CardiolRx failure
CardiolRx did not have a significant impact on left ventricular extracellular volume (LV-ECV) in the Phase II ARCHER study.
CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels
Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration SCOTTSDALE, AZ / ACCESS Newswire / August 5, 2025 / CBD Life Sciences Inc. (OTC:CBDL …
Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of …
Detailed price information for Artelo Biosciences Inc (ARTL-Q) from The Globe and Mail including charting and trades.
Flora Growth Corp. (FLGC) Leaps Into Web3 With $1M Crypto Bet
Flora Growth Corp. (NASDAQ:FLGC) is among the cheap pot stocks to buy. It is a global cannabis company headquartered in Fort Lauderdale, Florida, operating in over 15 countries. It offers a wide range …
Artelo Biosciences stock surges after receiving favorable UK regulatory guidance
Investing.com — Artelo Biosciences (NASDAQ: ARTL) stock surged 18% after the company received favorable guidance from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for a Phase 1 …
CBD Stocks Creating Opportunities – Established (BCCI), (STG), (WEED), (ACRGF), (RLTR), (CBMJ), and Newcomer (VAPR) Lead the Charge
You would have to be living in isolation to have not picked up on the hottest marijuana derivative consumable and therapeutic center isolate CBD. CBD “Cannabidiol” is the non-psychoactive full spectrum derivative of the hemp and marijuana plant largely credited for the majority of the medical beneficial attributes associated with marijuana.
Sydney to see eight new office projects until Q4 2027
These will yield nearly 200,000sqm of stock. There were three office completions in Sydney totalling 46,900 sqm over the second quarter and no withdrawals in the CBD, according to a JLL report. There …
Innocan Pharma’s CBD Technology Gains Traction at PAINWeek Conference
InnoCan Pharma ( ($TSE:INNO) ) has provided an update. Innocan Pharma’s presentation on its Liposomal Synthetic CBD Technology at the PAINWeek …
Elixinol Wellness to Quote 46.8 Million Securities on ASX
An announcement from Elixinol Wellness ( ($AU:EXL) ) is now available. Elixinol Wellness Limited has announced the quotation of 46,800,000 …
MediaX Agency Unveils Linkible — The AI-Powered Link Building Agency for Law Firms, SaaS, Cannabis & CBD, iGaming, Casino, and E-commerce
MediaX Agency Unveils Linkible — The AI-Powered Link Building Agency for Law Firms, SaaS, Cannabis & CBD, iGaming, Casino, and E-commerce …
InnoCan Pharma Stock: Nasdaq Listing Filing Signals Major Leap
InnoCan Pharma has officially filed registration documents with the SEC for a Nasdaq listing on July 23, 2025, marking a transformative moment for the Israeli-Canadian biotech company. The …
Cronos Group Inc. (CRON): A Bull Case Theory
This stock is one of several featured in our latest research. For more small-cap opportunities with asymmetric return potential, read our free article: 10 Promising SmallCap Stocks Under $1 Billion …
Weed can help your migraines, says new study — if you use it the right way
A landmark new study suggests that inhaling a precise blend of CBD and THC can provide fast, meaningful relief from migraines. The research — presented at the American Headache Society (AHS) Annual …
These CBD Gummies Are Formulated to Help You Fall (and Stay) Asleep
If you’re looking for something light to calm down and slowly drift off at night, these yummy gummies blend CBD with melatonin, a hormone that regulates the sleep-wake cycle, helping promote a sense …
Mizuho Reaffirms “Outperform” on Harmony Biosciences (HRMY) for BP1.15205 Data
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) is one of the 7 most undervalued pot stocks to buy according to analysts. On June 23, Mizuho reiterated its “Outperform” rating on Harmony and …
Recent Comments